Hence, one could speculate that transcriptional downregulation of endocannabinoid-degrading enzymes, possibly in response to later emerging metaflammation as shown for FAAH and TNFα [31], may represent a critical step in the development of hepatic alteration and metabolic disorder in obese subjects. This evidence concerns the gene FAAH and metabolic disease.